IntroductionThe global mesenchymal stem cells market is witnessing a significant transformation as advancements in ...

BioNTech will invest up to £1bn in UK life sciences over 10 years, launching new AI and R&D centres in London and Cambridge.

North Carolina’s success in regenerative medicine is due in part to its well-regarded life sciences industry, but equally also due to its strength in manufacturing. The state’s history in ...

It turns out SSRIs don’t just make our brains happier; they also make our T cells happier - even while they’re fighting ...

Aura Wellness today announced groundbreaking research demonstrating the effectiveness of its Pulsed Electromagnetic Field (PEMF) technology in treating benign prostatic hypertrophy (BPH). The study, ...

A new study has found the virus responsible for the common cold sore may have a role in the development of Alzheimer’s ...

The virus that causes cold sores is very common, but scientists say recent research should not be a cause for panic.

German biopharma company BioNTech has said it will commit up to £1 billion ($1.34 billion) in investment in the UK over the ...

Cambridge is set to become home to a major new research and development hub as part of a £1bn UK investment by biopharmaceutical firm BioNTech, expected to create more than 400 ...

This week a group of researchers, bioethicists, publishers and theologians are discussing the merits of human heritable genome editing.